BAX:NYSEBaxter International Inc. Analysis

Baxter International is trading at $17.4, well below its 20‑day ($19.58) and 50‑day ($19.99) moving averages, with a 30‑day RSI of 34 and a bearish MACD divergence, indicating short‑term oversold conditions but a prevailing downtrend. The stock sits near a $17 support level and faces resistance around $22.08, while volatility is elevated at 68% and beta exceeds 1, underscoring heightened price swings. Fundamentally, the company posted negative earnings (trailing EPS –$1.75) and a profit margin of –8.5%, yet the forward PE of 8.46 is dramatically lower than the industry average of 26.2, and the DCF‑derived fair value of $75.2 suggests a theoretical upside of roughly 24% if the model holds. However, the balance sheet is strained with a debt‑to‑equity ratio above 160% and a dividend payout ratio exceeding 300%, casting doubt on dividend sustainability. Recent news highlights robust Q4 sales growth but a sharp earnings miss and declining margins, reinforcing the mixed near‑term outlook.